Primary care diagnostic technology update: point-of-care testing for glycosylated haemoglobin.
CLINICAL QUESTION: In the monitoring of patients with type 1 and type 2 diabetes, what advantages does point-of-care HbA(1c) testing provide over current practice?
| Main Authors: | , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
2011
|